ASHR vs IBB
Xtrackers Harvest CSI 300 China A-Shares ETF vs iShares Biotechnology ETF
- • IBB has the lower expense ratio at 0.44% vs 0.65% for ASHR.
- • ASHR pays a higher dividend yield (2.07%).
Side-by-side metrics
| Metric | ASHR | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.65% | 0.44% |
Dividend yield Trailing 12-month yield. | 2.07% | 0.22% |
AUM Assets under management — bigger funds are typically more liquid. | $1.64B | $9.09B |
YTD return | 6.06% | 16.44% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.68 | 0.69 |
P/E ratio | 17.23 | 24.89 |
Last price | $35.88 | $197.34 |
Inception | — | — |
Issuer | Xtrackers | iShares |
ASHR top holdings
| 300308.SZ | Zhongji Innolight Co Ltd Class A | 4.80% |
| 300750.SZ | Contemporary Amperex Technology Co Ltd Class A | 3.53% |
| 300502.SZ | Eoptolink Technology Inc Ltd Class A | 2.88% |
| 600519.SS | Kweichow Moutai Co Ltd Class A | 2.51% |
| 603986.SS | GigaDevice Semiconductor Inc Class A | 1.87% |
| 601318.SS | Ping An Insurance (Group) Co. of China Ltd Class A | 1.72% |
| 688256.SS | Cambricon Technologies Corp Ltd Class A | 1.71% |
| 600036.SS | China Merchants Bank Co Ltd Class A | 1.50% |
| 601899.SS | Zijin Mining Group Co Ltd Class A | 1.42% |
| 002371.SZ | NAURA Technology Group Co Ltd Class A | 1.35% |
IBB top holdings
| VRTX | Vertex Pharmaceuticals Inc | 8.07% |
| AMGN | Amgen Inc | 7.82% |
| GILD | Gilead Sciences Inc | 6.83% |
| REGN | Regeneron Pharmaceuticals Inc | 4.90% |
| ARGX | argenx SE ADR | 3.75% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.12% |
| NTRA | Natera Inc | 2.89% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% |
| BIIB | Biogen Inc | 2.46% |
| ILMN | Illumina Inc | 2.07% |
About ASHR
ASHR (Xtrackers Harvest CSI 300 China A-Shares ETF) is China A-shares listed on Shanghai and Shenzhen exchanges. Managed by Xtrackers, the fund carries $1.6B in assets under management, an expense ratio of 0.65%, a dividend yield of 2.07%. Its largest holding is Zhongji Innolight Co Ltd Class A (300308.SZ), which represents 4.8% of the portfolio. Real Estate is the fund's largest sector exposure at 0.3%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $9.1B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.22%. Its largest holding is Vertex Pharmaceuticals Inc (VRTX), which represents 8.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.